Short Read Sequencing Market Analysis 2025–2029: Growth Forecast and Competitive Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the short read sequencing market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Short Read Sequencing Market Be Worth By 2029, And What CAGR Will It Achieve?

The short read sequencing market size has experienced swift expansion recently. The market is anticipated to expand from $6.66 billion in 2024 to $7.8 billion in 2025, at a compound annual growth rate (CAGR) of 17.2%. This historical growth can be attributed to factors like genomic research initiatives, the increased prevalence of genetic disorders, pharmaceutical and biotech research, diagnostic applications, and a decline in sequencing costs.

The short read sequencing market is poised for substantial growth over the next few years, with its size forecast to reach $15.06 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 17.9%. This expansion throughout the forecast period can be primarily attributed to advancements in precision medicine, the rapid acceleration of personalized genomics, broadening applications within agriculture, a surge in microbiome research, and an increasing demand from emerging markets. Significant trends expected during this time include heightened automation and high-throughput capabilities, the adoption of cloud-based solutions, the integration of artificial intelligence and machine learning, the emergence of portable sequencing technologies, and a synergistic interaction with long-read sequencing.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11912&type=smp

Which Factors Are Driving The Short Read Sequencing Market Forward?

The increasing incidence of genetic diseases is anticipated to drive the expansion of the short-read sequencing market going forward. Genetic diseases refer to conditions caused by anomalies or mutations in an individual’s DNA or genes, which can lead to physical, developmental, or biochemical irregularities impacting their health and overall well-being. Short-read sequencing is utilized in the realm of genetic diseases for a thorough analysis of the genome and to identify variations associated with diseases. For example, in June 2022, a report from RARE-X, an Australia-based patient support platform, stated that there were a total of 10,867 rare diseases, comprising both genetic and non-genetic conditions. Therefore, the growing prevalence of genetic diseases is a key factor propelling the growth of the short-read sequencing market.

Which Segments Form The Key Structure Of The Short Read Sequencing Market?

The short read sequencingmarket covered in this report is segmented –

1) By Product: Instruments, Consumables, Services.

2) By Technology: Next-Generation Sequencing, Sanger Sequencing.

3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis.

4) By Application: Clinical Investigation, Oncology, Reproductive Health, Consumer Genomics, Agri genomics And Forensics, HLA Typing Or Immune System Monitoring.

5) By End Users: Academic Research, Hospitals And Clinics, Clinical Research, Pharmaceutical And Biotechnology Companies.

Subsegments:

1) By Instruments: Next-Generation Sequencing (NGS) Systems, Sequencing Platforms, Library Preparation Systems

2) By Consumables: Reagents And Kits, Flow Cells, Sample Preparation Consumables

3) By Services: Sequencing Services, Data Analysis Services, Bioinformatics Services

What Strategic Shifts And Innovations Are Influencing The Short Read Sequencing Market?

Technological progress stands out as a significant trend growing in prominence within the short-read sequencing market. Leading firms operating in the short-read sequencing market are concentrating on technological improvements to enhance their analytical capabilities and maintain their competitive standing. As an example, in October 2022, Pacific Biosciences Inc., a US-based manufacturer of high-quality, precise sequencing technologies, initiated external beta testing for its Onso sequencing system. This system was engineered to deliver accurate data alongside offering cost efficiency. The short-read platform was created to provide oncology researchers with sensitive and specific results from targeted sequence analysis.

Which Firms Are Making The Biggest Impact In The Short Read Sequencing Market?

Major companies operating in the short read sequencing market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Cytiva Lifesciences, Eurofins Scientific SE, Agilent Technologies Inc., Beckman Coulter Inc., Illumina Inc., QIAGEN N.V., PerkinElmer Inc., BGI Genomics Co Ltd, MGI Tech Co. Ltd., GenScript Biotech Corporation., 10x Genomics Inc., Novogene Co. Ltd, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., Genewiz Inc., Zymo Research Corporation, GenapSys Inc., Fasteris SA, Paragon Genomics Inc., Nabsys Inc., GATC Biotech AG

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

Which Region Is Expected To Lead The Short Read Sequencing Market In The Next Few Years?

North America was the largest region in the Short Read Sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short read sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=11912&type=smp

Browse Through More Reports Similar to the Global Short Read Sequencing Market 2025, By The Business Research Company

Rna Analysis Transcriptomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Antisense And Rnai Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795